Citation | Cadilla, R; Deaton, DN; Do, Y; Elkins, PA; Ennulat, D; Guss, JH; Holt, J; Jeune, MR; King, AG; Klapwijk, JC; Kramer, HF; Kramer, NJ; Laffan, SB; Masuria, PI; McDougal, AV; Mortenson, PN; Musetti, C; Peckham, GE; Pietrak, BL; Poole, C; Price, DJ; Rendina, AR; Sati, G; Saxty, G; Shearer, BG; Shewchuk, LM; Sneddon, HF; Stewart, EL; Stuart, JD; Thomas, DN; Thomson, SA; Ward, P; Wilson, JW; Xu, T; Youngman, MA The exploration of aza-quinolines as hematopoietic prostaglandin D synthase (H-PGDS) inhibitors with low brain exposure. Bioorg Med Chem28:0 (2020) [PubMed] |
---|
SMILES | FC1(F)CN(C1)[C@H]1CC[C@@H](CC1)NC(=O)c1cnc2nc(ccc2c1)C1CC1 |r,wU:9.13,wD:6.6,(9.82,3.25,;8.27,3.25,;9.04,4.58,;7.87,1.74,;6.38,2.14,;6.78,3.65,;5.05,1.37,;3.71,2.14,;2.38,1.37,;2.38,-.17,;3.71,-.94,;5.05,-.17,;1.04,-.94,;-.29,-.17,;-.29,1.37,;-1.62,-.94,;-1.62,-2.48,;-2.95,-3.25,;-4.29,-2.48,;-5.61,-3.24,;-6.94,-2.48,;-6.94,-.96,;-5.63,-.18,;-4.29,-.95,;-2.96,-.17,;-8.27,-3.25,;-9.82,-3.25,;-9.04,-4.58,)| |